CIK 0000728387 · Non-accelerated filer<br>Smaller reporting company
Perspective Therapeutics, Inc.
Sign in to watch- Ticker
- CATX
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 411458152
- Phone
- 206-676-0900
- Business address
- 2401 ELLIOTT AVENUE, SUITE 320, SEATTLE, WA, 98121
- Former names
- IsoRay, Inc., Isoray, Inc., CENTURY PARK PICTURES CORP
- Open-market buys, last 90 days
- $72,488
- in 2 filings
- Open-market sales, last 90 days
- $1,622,534
- in 5 filings
Net −$1,550,047. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-11-16 | Vitale Philip J Director | Purchase | +1,606 | $0.44 | $707 | 55,353 |
| 2017-11-16 | Vitale Philip J Director | Purchase | +496 | $0.44 | $218 | 55,849 |
| 2017-11-16 | Vitale Philip J Director | Purchase | +300 | $0.44 | $131 | 56,149 |
| 2017-11-16 | Vitale Philip J Director | Purchase | +300 | $0.44 | $133 | 56,449 |
| 2017-11-16 | Vitale Philip J Director | Purchase | +12,851 | $0.45 | $6K | 69,300 |
| 2017-11-16 | Vitale Philip J Director | Purchase | +600 | $0.45 | $269 | 69,900 |
| 2017-11-16 | Vitale Philip J Director | Purchase | +100 | $0.44 | $44 | 70,000 |
| 2017-06-27 | Krachon Michael VP of Sales & Marketing | Grant or award · Stock Options (right to buy) | +225,000 | 0 | ||
| 2017-06-27 | McCormick Michael W Director | Grant or award · Stock Options (right to buy) | +5,000 | 0 | ||
| 2017-06-27 | LAVOY THOMAS C CEO | Grant or award · Stock Options (right to buy) | +715,000 | 0 | ||
| 2017-06-27 | Vitale Philip J Director | Grant or award · Stock Options (right to buy) | +5,000 | 0 | ||
| 2017-06-27 | McCormick Michael W Director | Grant or award · Stock Options (right to buy) | +5,000 | 0 | ||
| 2017-06-27 | Hoffmann Alan Director | Grant or award · Stock Options (right to buy) | +5,000 | 0 | ||
| 2017-06-27 | Cavanagh William COO, CSO | Grant or award · Stock Options (right to buy) | +225,000 | 0 | ||
| 2017-06-27 | Krachon Michael VP of Sales & Marketing | Grant or award · Stock Options (right to buy) | +225,000 | 0 | ||
| 2017-06-27 | LAVOY THOMAS C CEO | Grant or award · Stock Options (right to buy) | +715,000 | 0 | ||
| 2017-06-27 | Streeter Jennifer VP of Human Resources | Grant or award · Stock Options (right to buy) | +100,000 | 0 | ||
| 2017-06-15 | Branson Matthew Principal Fin & Acct Officer | Returned to the company · Stock Options (right to buy) | −15,000 | 0 | ||
| 2017-06-15 | Branson Matthew Principal Fin & Acct Officer | Returned to the company · Stock Options (right to buy) | −25,000 | 0 | ||
| 2017-06-15 | Krachon Michael VP of Sales & Marketing | Returned to the company · Stock Options (right to buy) | −125,000 | 0 |
Page 14 of 26 · 504 trades